We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.71%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.11B
AUM Growth
+$140M
(+4.7%)
Cap. Flow
-$15.5M
Cap. Flow
% of AUM
-0.5%
Top 10 Holdings %
Top 10 Hldgs %
31.89%
Holding
3,618
New
197
Increased
1,211
Reduced
1,199
Closed
259
Avg Time Held Equity + Options
3.7
years
Top 10 Avg Time Held Equity + Options
2.1
years
Top 20 Avg Time Held Equity + Options
2.5
years
Avg Time Held Equity only
3.7
years
Top 10 Avg Time Held Equity only
2.1
years
Top 20 Avg Time Held Equity only
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$72.4M |
| 2 |
iShares 10-20 Year Treasury Bond ETF
TLH
|
+$18.9M |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
+$9.7M |
| 4 |
iShares MSCI EAFE Growth ETF
EFG
|
+$3.85M |
| 5 |
Confluent
CFLT
|
+$3.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$39.5M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$19.1M |
| 3 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$18.1M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$16.4M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$7.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.46% |
| 2 | Technology | 15.44% |
| 3 | Healthcare | 8.51% |
| 4 | Financials | 6.64% |
| 5 | Consumer Discretionary | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3251
Zumiez
ZUMZ
$221M
| $167 | ﹤0.01% |
10
-66
| -87% | -$1.1K |
2020 Q2
12 quarters
|
|
3252
Gladstone Capital
GLAD
$437M
| $166 | ﹤0.01% |
9
+1
| +13% | +$19 |
2021 Q4
6 quarters
|
|
3253
Loop Industries
LOOP
$18M
| $161 | ﹤0.01% |
50
| – | – |
2018 Q3
19 quarters
|
|
3254
Sana Biotechnology
SANA
$742M
| $161 | ﹤0.01% |
+27
| New | +$156 |
2023 Q2
0 quarters
|
|
3255
DELISTED
Merus
MRUS
| $158 | ﹤0.01% |
6
| – | – |
2023 Q1
1 quarter
|
|
3256
Bread Financial
BFH
$3.89B
| $157 | ﹤0.01% |
5
-158
| -97% | -$4.54K |
2016 Q4
26 quarters
|
|
3257
InMode
INMD
$824M
| $149 | ﹤0.01% |
4
-16
| -80% | -$559 |
2022 Q2
4 quarters
|
|
3258
Star Holdings Shares of Beneficial Interest
STHO
$96.8M
| $147 | ﹤0.01% |
10
-43
| -81% | -$681 |
2023 Q1
1 quarter
|
|
3259
Altimmune
ALT
$459M
| $141 | ﹤0.01% |
40
| – | – |
2021 Q1
9 quarters
|
|
3260
Replimune Group
REPL
$1.11B
| $139 | ﹤0.01% |
6
-4
| -40% | -$78 |
2022 Q2
4 quarters
|
|
3261
MYR Group
MYRG
$4.45B
| $138 | ﹤0.01% |
1
| – | – |
2022 Q3
3 quarters
|
|
3262
Alpha and Omega Semiconductor
AOSL
$707M
| $131 | ﹤0.01% |
4
-16
| -80% | -$430 |
2023 Q1
1 quarter
|
|
3263
Comtech Telecommunications
CMTL
$43.4M
| $128 | ﹤0.01% |
14
-45
| -76% | -$483 |
2021 Q1
9 quarters
|
|
3264
Semtech
SMTC
$13.5B
| $127 | ﹤0.01% |
5
-357
| -99% | -$7.71K |
2019 Q3
15 quarters
|
|
3265
MaxLinear
MXL
$7.09B
| $126 | ﹤0.01% |
4
-72
| -95% | -$2.08K |
2022 Q1
5 quarters
|
|
3266
DELISTED
Squarespace, Inc.
SQSP
| $126 | ﹤0.01% |
4
-70
| -95% | -$2.12K |
2022 Q4
2 quarters
|
|
3267
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $125 | ﹤0.01% |
50
| – | – |
2022 Q3
3 quarters
|
|
3268
Centerspace
CSR
$940M
| $123 | ﹤0.01% |
+2
| New | +$117 |
2023 Q2
0 quarters
|
|
3269
DELISTED
bluebird bio
BLUE
| $122 | ﹤0.01% |
+2
| New | +$146 |
2023 Q2
0 quarters
|
|
|
VIEW
3270
DELISTED
View, Inc. Class A Common Stock
VIEW
| $121 | ﹤0.01% |
17
| – | – |
2021 Q2
8 quarters
|
|
3271
Acco Brands
ACCO
$423M
| $120 | ﹤0.01% |
23
| – | – |
2021 Q1
9 quarters
|
|
3272
OneSpan
OSPN
$659M
| $119 | ﹤0.01% |
8
| – | – |
2021 Q2
8 quarters
|
|
3273
CALL
Mercado Libre
MELI
$94.1B
| $118 | ﹤0.01% |
+100
| New | +$126K |
2023 Q2
0 quarters
|
|
3274
Ultra Clean Holdings
UCTT
$2.53B
| $115 | ﹤0.01% |
3
| – | – |
2021 Q3
7 quarters
|
|
3275
Cartesian Therapeutics
RNAC
$199M
| $112 | ﹤0.01% |
3
| – | – |
2020 Q4
10 quarters
|
|
Similar funds
Parallel Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Parallel Advisors held 3,618 positions worth $3.11B, up 4.7% from $2.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Parallel Advisors's Q2 2023 filing shows 197 new, 1,211 increased, 1,199 reduced and 259 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 11,017 shares worth $533K. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $39.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 50% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2023 buy was JPMorgan Nasdaq Equity Premium Income ETF: 11,017 shares worth $533K.
- Parallel Advisors added most to iShares MSCI USA Quality Factor ETF in Q2 2023, an estimated $72.4M increase.
- Parallel Advisors's biggest Q2 2023 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $39.5M.
- Parallel Advisors fully exited Cvent Holding Corp. Common Stock in Q2 2023, selling an estimated $1.62M.
- Parallel Advisors's ten largest holdings make up 32% of its $3.11B portfolio in Q2 2023.
- Parallel Advisors opened 197 new positions and closed 259 in Q2 2023.
- Parallel Advisors's portfolio value rose 4.7% quarter-over-quarter to $3.11B.
Based on Parallel Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.